Daewon Chemical

At a glance

Daewon Chemical filed 38 disclosures in the last 12 months, including 5 insider, 2 5% holder and 1 buyback. The most recent key filing was on Oct 20.

Revenue for 2025 was ₩126B, up 0.4% on 2024. Operating margin was 0.7% against -4.9% a year earlier. Debt was 233% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩69.6B and operating profit of ₩122.5M.

The 2025 annual report lists 85 employees with an average tenure of 6.9 years and average pay of ₩51.3M, #1391 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩36M each on average. It paid no cash dividend for 2025. 강동엽 and related parties held 46.88% at year end.

From the 2025 annual report

Staff: 85 (70 men, 15 women), of whom 22 on fixed-term contracts. Total pay for the year: ₩3.8B. Directors and auditors: 5, paid ₩178M in total.

No cash dividend was paid for 2025.

Largest shareholder

강동엽 holds 11.76%; with 6 related parties the group holds 46.88% of common shares at year end.

Auditor: 한울회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary